Daria Kania Ph.D. (ORCID ID: 0000-0002-1396-0014) completed her master’s degree in Biomedical Sciences with distinction at Lancaster University in the UK. She obtained her PhD in Biomedical Sciences from Lancaster University in 2021 defending her thesis entitled “Minimal toolkits for eukaryotic DNA repair”. Since 2021, she has been working at the Centre for Translational Research and Molecular Biology of Cancer at the Maria Skłodowska-Curie National Research Institute of Oncology. Initially, she worked as a post-doctoral researcher in the Laboratory of Heat Shock Proteins, in the team of Dorota Ścieglińska, Ph.D., carrying out research in the project “Role of the chaperone protein HSPA2 in physiology and pathophysiology of human epidermis”. In 2023, she joined the Laboratory of Clinical Proteomics, where she is conducting research in the project entitled “Exosomes as a potential biomarker for monitoring and predicting transplanted kidney rejection”.